Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Hartford

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Biopharmaceutical Statistics|October 19, 2012
A Bayesian approach for PK/PD modeling with PD data below limit of quantificationHuafeng Zhou, Alan Hartford, Kuenhi Tsai
Contemporary Clinical Trials Communications|May 13, 2020
A model-based approach for simulating adaptive clinical studies with surrogate endpoints used for interim decision-makingXiaotian Chen, Alan Hartford, Jun Zhao
Pharmaceutical Statistics|September 1, 2018
Bayesian detection of potential risk using inference on blinded safety dataSaurabh Mukhopadhyay, Brian Waterhouse, Alan Hartford
Journal of Biopharmaceutical Statistics|April 17, 2020
Modified Goldilocks Design with strict type I error control in confirmatory clinical trialsTianyu Zhan, Hongtao Zhang, Alan Hartford, et al.
Statistics in Biopharmaceutical Research|April 11, 2022
Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep LearningTianyu Zhan, Alan Hartford, Jian Kang, et al.
Journal of Biopharmaceutical Statistics|June 1, 2005
A comparison of nonlinear mixed-model analyses for a pediatric pharmacokinetic studyAlan Hartford, Elizabeth Migoya, Lata Maganti, et al.
Pharmaceutical Statistics|November 2, 2021
Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluationBrian Waterhouse, Alan Hartford, Saurabh Mukhopadhyay, et al.
Archives of Drug Information|August 6, 2010
Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of MontelukastBarbara Knorr, Alan Hartford, Xiujiang Susie Li, et al.
Advances in Experimental Medicine and Biology|March 6, 2010
Clinical electron paramagnetic resonance (EPR) oximetry using India inkBenjamin B Williams, Nadeem Khan, Bassem Zaki, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Adaptive Designs: Results of 2016 Survey on Perception and UseAlan Hartford, Mitchell Thomann, Xiaotian Chen, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Biopharmaceutical Statistics|October 19, 2012
A Bayesian approach for PK/PD modeling with PD data below limit of quantificationHuafeng Zhou, Alan Hartford, Kuenhi Tsai
Contemporary Clinical Trials Communications|May 13, 2020
A model-based approach for simulating adaptive clinical studies with surrogate endpoints used for interim decision-makingXiaotian Chen, Alan Hartford, Jun Zhao
Pharmaceutical Statistics|September 1, 2018
Bayesian detection of potential risk using inference on blinded safety dataSaurabh Mukhopadhyay, Brian Waterhouse, Alan Hartford
Journal of Biopharmaceutical Statistics|April 17, 2020
Modified Goldilocks Design with strict type I error control in confirmatory clinical trialsTianyu Zhan, Hongtao Zhang, Alan Hartford, et al.
Statistics in Biopharmaceutical Research|April 11, 2022
Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep LearningTianyu Zhan, Alan Hartford, Jian Kang, et al.
Journal of Biopharmaceutical Statistics|June 1, 2005
A comparison of nonlinear mixed-model analyses for a pediatric pharmacokinetic studyAlan Hartford, Elizabeth Migoya, Lata Maganti, et al.
Pharmaceutical Statistics|November 2, 2021
Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluationBrian Waterhouse, Alan Hartford, Saurabh Mukhopadhyay, et al.
Archives of Drug Information|August 6, 2010
Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of MontelukastBarbara Knorr, Alan Hartford, Xiujiang Susie Li, et al.
Advances in Experimental Medicine and Biology|March 6, 2010
Clinical electron paramagnetic resonance (EPR) oximetry using India inkBenjamin B Williams, Nadeem Khan, Bassem Zaki, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Adaptive Designs: Results of 2016 Survey on Perception and UseAlan Hartford, Mitchell Thomann, Xiaotian Chen, et al.
Pageof 3